To access this element change to forms mode OFF
Grant Award View - GA40801
The Candesartan Adjunctive bipolar DEpression Trial - CADET
GA ID:
GA40801
Agency:
Department of Health and Aged Care
Approval Date:
29-Mar-2019
Publish Date:
26-Apr-2019
Category:
Medical Research
Grant Term:
1-Apr-2019 to 31-Mar-2024
Value (AUD):
$2,428,397.10
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 18/19 1.1 Health and Medical Research
Grant Program:
2018_MRFF Rare Cancers Rare Diseases, Unmet Need_commencing_2018
Grant Activity:
The Candesartan Adjunctive bipolar DEpression Trial - CADET
Purpose:
This project aims to define a novel treatment for bipolar depression - the major unmet need in the disorder - by targeting angiotensin, a key modulator of the stress response and immune systems. We have compelling preclinical, epidemiological and clinical data supporting the potential value of angiotensin medications in improving mood. We propose to conduct the first double-blind, placebo-controlled trial of candesartan, an angiotensin receptor blocker, to treat bipolar depression.
GO ID:
GO Title:
Medical Research Future Fund Clinical Trials Activity – Rare Cancers, Rare Diseases and Unmet Need Grant Opportunity
Internal Reference ID:
MRF1169845
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Deakin University
Recipient ABN:
56 721 584 203
Grant Recipient Location
Suburb:
Waurn Ponds
Town/City:
Waurn Ponds
Postcode:
3216
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA